Geode Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $160M | Buy |
|
|||||
|
2025
Q1 | $141M | Sell |
|
|||||
|
2024
Q4 | $204M | Buy |
|
|||||
|
2024
Q3 | $158M | Buy |
|
|||||
|
2024
Q2 | $138M | Buy |
|
|||||
|
2024
Q1 | $114M | Buy |
|
|||||
|
2023
Q4 | $80.9M | Buy |
|
|||||
|
2023
Q3 | $76.2M | Buy |
|
|||||
|
2023
Q2 | $53.6M | Buy |
|
|||||
|
2023
Q1 | $59.6M | Buy |
|
|||||
|
2022
Q4 | $59.5M | Sell |
|
|||||
|
2022
Q3 | $53.4M | Buy |
|
|||||
|
2022
Q2 | $47.4M | Buy |
|
|||||
|
2022
Q1 | $57M | Buy |
|
|||||
|
2021
Q4 | $47.3M | Buy |
|
|||||
|
2021
Q3 | $55.5M | Buy |
|
|||||
|
2021
Q2 | $51.2M | Buy |
|
|||||
|
2021
Q1 | $54.1M | Sell |
|
|||||
|
2020
Q4 | $47.2M | Buy |
|
|||||
|
2020
Q3 | $38.9M | Buy |
|
|||||
|
2020
Q2 | $53.2M | Buy |
|
|||||
|
2020
Q1 | $38.4M | Buy |
|
|||||
|
2019
Q4 | $41.6M | Buy |
|
|||||
|
2019
Q3 | $28.6M | Buy |
|
|||||
|
2019
Q2 | $35.1M | Buy |
|
|||||
|
2019
Q1 | $50.9M | Buy |
|
|||||
|
2018
Q4 | $48.1M | Buy |
|
|||||
|
2018
Q3 | $61.2M | Buy |
|
|||||
|
2018
Q2 | $65.5M | Buy |
|
|||||
|
2018
Q1 | $42.3M | Buy |
|
|||||
|
2017
Q4 | $43.7M | Buy |
|
|||||
|
2017
Q3 | $39M | Buy |
|
|||||
|
2017
Q2 | $72.5M | Buy |
|
|||||
|
2017
Q1 | $59.6M | Buy |
|
|||||
|
2016
Q4 | $62.5M | Buy |
|
|||||
|
2016
Q3 | $9.13M | Buy |
|
|||||
|
2016
Q2 | $9.02M | Buy |
|
|||||
|
2016
Q1 | $9.45K | Sell |
|
|||||
|
2015
Q4 | $12.1M | Buy |
|
|||||
|
2015
Q3 | $10.3M | Sell |
|
|||||
|
2015
Q2 | $11.2M | Buy |
|
|||||
|
2015
Q1 | $11.1M | Buy |
|
|||||
|
2014
Q4 | $8.54M | Buy |
|
|||||
|
2014
Q3 | $6.64M | Buy |
|
|||||
|
2014
Q2 | $5.19M | Buy |
|
|||||
|
2014
Q1 | $3.98M | Buy |
|
|||||
|
2013
Q4 | $2.07M | Sell |
|
|||||
|
2013
Q3 | $2.12M | Buy |
|
|||||
|
2013
Q2 | $1.87M | Buy |
|